Radcliffe Group Ltd Appoints New Chief Technical Officer and Scientific Director

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

August 27, 2020

Radcliffe Group Ltd. has announced the appointment of a new chief technical officer and scientific director.

Wells Powell, Radcliffe GroupRadcliffe Group reports: Wells Powell (top right) has been working in technology for over 25 years and spent most of his career working as part of the IT Management team at French Bank BNP Paribas. Wells has held senior roles across development and production, managing large teams across multiple territories. During a career of over 21 years at BNPP, Wells was responsible for leading several strategic projects across electronic trading, eCommerce and digital transformation. His role as CTO at RG will be pivotal to the strategic implementation of the technological infrastructure associated with their data analytics and media production development plans.

Wells Powell comments: “After working with RG on their continued digital transformation as a consultant for 18 months, I am excited to be joining RG on a permanent basis and being involved more formally in the digital strategy of the company. RG delivers high-quality digital content and continually push boundaries to bring new and innovative products for the advancement of educating cardiovascular physicians to market. I look forward to being involved in their continuous growth with this ambitious team.”

Sean Delaney (bottom-right) joins RG with a wealth of Medical Education and Communications experience, most recently from his Board position at OmniaMed Communications where he managed the editorial team, led the scientific strategy, and approved all medical content. Prior to that role, Sean was Principal Medical Writer at PCM Scientific. His most notable work included the execution of an award-winning CME-accredited outreach program in heart failure (Winner, Communique Awards 2017). Sean’s appointment further emphasizes RG’s commitment to the production of world-class medical content. His experience will see him working closely with the existing Chief Scientific Officer, Dr. Greg Guillory, to oversee the content development process from inception ensuring highest quality standards are adhered to and learning objectives obtained.

Sean Delaney comments: “Having watched from the sideline for several years, I’ve been consistently impressed by the quality and innovation of RG’s digitally-focused content. I’m excited to be joining the team and also bringing some of my own insight and experience from the world of cardiology, to continue the success of RG’s medical education.”

Liam O’Neill, COO, RG comments: “Both David, myself and the board of directors are delighted that Wells and Sean have chosen Radcliffe Group for the next chapter of their careers. Both have considerable reputations in their respective fields of specialism and it is a real coup to bring them into the leadership group of our growing company. Their expertise and enthusiasm will be crucial to enabling the business to maximize its potential in the coming months and years. We are really excited to welcome them to the Radcliffe team and witness the impact they will inevitably make.”

Radcliffe Group Ltd is the holding company of operating businesses Radcliffe Medical Media and Radcliffe Medical Education. Radcliffe Medical Media comprises the Radcliffe Cardiology and Radcliffe Vascular content platforms, publishing six industry-leading open access, peer-reviewed journals: Arrhythmia & Electrophysiology Review (AER), Cardiac Failure Review (CFR)European Cardiology Review (ECR)Interventional Cardiology Review (ICR)US Cardiology Review (USC) and Vascular & Endovascular Review (VER). Radcliffe Medical Education delivers trusted independent CME accredited and non-accredited educational programs in multiple media formats for the benefit of cardiovascular physicians globally, via its learning management web platform, Radcliffe Education and during in-person medical congresses.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.